Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: One Week Of IPOs Total $818.2m

Relay, Berkeley Lights, ALX Oncology And Pandion Launched Last Week

Jul 17 2020

• By Mandy Jackson

Finance Watch

Related Content

Cubist buys private antibiotic firm for up to $403 million

Dec 15 2009

Asia Deal Watch: Zogenix Partners Japanese Rights To Pediatric Epilepsy Therapy To Nippon Shinyaku

Mar 20 2019

Can Editas, BeiGene Offerings Redeem US IPO Class Of 2015?

Feb 04 2016

Adimab turns profit on deals with GSK, Biogen

Jul 27 2013

Asia Deal Watch: China’s BravoVax, US-based GeoVax Team Up On Coronavirus Vaccine

Jan 31 2020

Venture Funding Deals: ALX Oncology, Transcenta Break $100m Barrier With Recent Rounds

Mar 03 2020

Deal Watch: Altimmune Moves Into NASH With Purchase Of Spitfire

Jul 09 2019

Finance Watch: Gene Therapy, Targeted Oncology Driving IPOs Despite Biopharma Stock Shakiness

Jul 02 2019

Private Adimab Breaks $1 Billion Valuation, Offers VCs Liquidity Through $100 Million Secondary

Feb 06 2015

Sosei Heptares Seeks Acquisitions After $200m Boost

Jul 16 2020

Finance Watch: Poseida, Nkarta And Inventiva Are July’s First Biopharma IPOs

Jul 10 2020

Deal Watch: Merck's Busy Stretch Includes Collaborations With Dewpoint, Zymeworks

Jul 13 2020

Coronavirus Update: 'We Are Racing Against The Virus, Not America,' Says China’s Vaccine Frontrunner

Jul 17 2020

Asia Deal Watch: Innovent Picks Up Asian Rights To Three Clinical Cancer Candidates From Incyte

Dec 20 2018

Finance Watch: Relay Raises $400m – And It's Only The Third-Largest Biopharma VC Round Of 2018

Dec 21 2018

Heart Failure Pipeline Review: Amgen's Omecamtiv And Merck's Vericiguat Step Up To Plate

Feb 16 2018

Finance Watch: Ascletis First Biotech To List Under New Hong Kong Rules, BeiGene Joins In

Aug 03 2018

Amicus' Oral Fabry Drug Priced To Compete Against Traditional ERT

Aug 13 2018

The Future Of Medicine: Cell And Gene Therapies Take The Lead

Jun 11 2020

MyoKardia Readies First-Ever Hypertrophic Cardiomyopathy Drug For US Filing

May 12 2020

Deal Watch: Bayer Teams With Nuvisan On Berlin-Based Small Molecule Research Group

Feb 14 2020

Novartis to pay up to $620 million for Corthera

Dec 23 2009

Finance Watch: Investors Bet On Hope As Four Early-Stage Companies Launch US IPOs

Jun 21 2019

Finance Watch: iTeos, Pandion And Aspen Show COVID-19 Hasn’t Slowed VC Deals Yet

Apr 01 2020

Amgen, Adaptive Partner In COVID-19 Neutralizing Antibody R&D Effort

Apr 02 2020

IPO Update: High-Flying Biopharma IPOs Average 77.1% Return Through Q2

Jun 30 2020

Verona Details COPD Opportunity For Ensifentrine

Jun 02 2020

Related Companies

Relay Therapeutics, Inc.

PhenomeX

ALX Oncology, Inc.

Pandion Therapeutics, Inc.

Ocumension Therapeutics

EyePoint Pharmaceuticals, Inc.

Poseida Therapeutics, Inc.

Nkarta, Inc.

Inventiva S.A.

BeOne Medicines Ltd.

Cytokinetics, Inc.

CORXEL Pharmaceuticals (Shanghai) Co., Ltd.

MyoKardia, Inc.

Amicus Therapeutics, Inc.

Verona Pharma plc

Altimmune Inc.

Atreca, Inc.

Merck & Co., Inc.

Xencor, Inc.

Imvax Inc.

Additional Topics

Financing Business Strategies Innovation StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.